303 related articles for article (PubMed ID: 16836305)
1. Large-scale oxidations in the pharmaceutical industry.
Caron S; Dugger RW; Ruggeri SG; Ragan JA; Ripin DH
Chem Rev; 2006 Jul; 106(7):2943-89. PubMed ID: 16836305
[No Abstract] [Full Text] [Related]
2. High-throughput and parallel screening methods in asymmetric hydrogenation.
Jäkel C; Paciello R
Chem Rev; 2006 Jul; 106(7):2912-42. PubMed ID: 16836304
[No Abstract] [Full Text] [Related]
3. Industrial biotransformations in the synthesis of building blocks leading to enantiopure drugs.
Muñoz Solano D; Hoyos P; Hernáiz MJ; Alcántara AR; Sánchez-Montero JM
Bioresour Technol; 2012 Jul; 115():196-207. PubMed ID: 22230779
[TBL] [Abstract][Full Text] [Related]
4. Palladium coupling catalysts for pharmaceutical applications.
Doucet H; Hierso JC
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):672-90. PubMed ID: 17987520
[TBL] [Abstract][Full Text] [Related]
5. Ozonolysis applications in drug synthesis.
Van Ornum SG; Champeau RM; Pariza R
Chem Rev; 2006 Jul; 106(7):2990-3001. PubMed ID: 16836306
[No Abstract] [Full Text] [Related]
6. Multicomponent reactions in solid-phase synthesis.
Banfi L; Guanti G; Riva R; Basso A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
[TBL] [Abstract][Full Text] [Related]
7. Drug discovery: the leading edge.
Chapman T
Nature; 2004 Jul; 430(6995):109-15. PubMed ID: 15229608
[No Abstract] [Full Text] [Related]
8. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
[No Abstract] [Full Text] [Related]
9. Lessons from natural molecules.
Clardy J; Walsh C
Nature; 2004 Dec; 432(7019):829-37. PubMed ID: 15602548
[TBL] [Abstract][Full Text] [Related]
10. Aligning pharmaceutical innovation with medical need.
Nathan C
Nat Med; 2007 Mar; 13(3):304-8. PubMed ID: 17342145
[No Abstract] [Full Text] [Related]
11. Continuous flow synthesis. A pharma perspective.
Malet-Sanz L; Susanne F
J Med Chem; 2012 May; 55(9):4062-98. PubMed ID: 22283413
[No Abstract] [Full Text] [Related]
12. Forging synergies in drug discovery.
Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
[No Abstract] [Full Text] [Related]
13. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
Fortunak J; Confalone PN; Grosso JA
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
[No Abstract] [Full Text] [Related]
14. Results from a bench marking survey on Supporting Chemical Synthesis and Structural Elucidation in the Pharmaceutical Industry.
Peake DA; Ackermann BL
J Am Soc Mass Spectrom; 2005 Apr; 16(4):599-605. PubMed ID: 15871168
[No Abstract] [Full Text] [Related]
15. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
Rantanen J; Khinast J
Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
[No Abstract] [Full Text] [Related]
16. [Strategy of molecular drug design: hits, leads and drug candidates].
Guo ZR
Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
[TBL] [Abstract][Full Text] [Related]
17. A return to the fundamentals of drug discovery?
Williams M
Curr Opin Investig Drugs; 2004 Jan; 5(1):29-33. PubMed ID: 14983970
[No Abstract] [Full Text] [Related]
18. Synthetic peptide API manufacturing: A mini review of current perspectives for peptide manufacturing.
Rasmussen JH
Bioorg Med Chem; 2018 Jun; 26(10):2914-2918. PubMed ID: 29735426
[No Abstract] [Full Text] [Related]
19. Current and future impact of green chemistry on the pharmaceutical industry.
Fortunak JM
Future Med Chem; 2009 Jul; 1(4):571-5. PubMed ID: 21426025
[No Abstract] [Full Text] [Related]
20. Boron reagents in process chemistry: Excellent tools for selective reductions.
Burkhardt ER; Matos K
Chem Rev; 2006 Jul; 106(7):2617-50. PubMed ID: 16836295
[No Abstract] [Full Text] [Related]
[Next] [New Search]
